These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6890819)

  • 1. Effects of flecainide on contractile force and electrophysiological parameters in cardiac muscle.
    Schulze JJ; Knops J
    Arzneimittelforschung; 1982; 32(9):1025-9. PubMed ID: 6890819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of flecainide on action potentials and alternating current-induced arrhythmias in mammalian myocardium.
    Borchard U; Boisten M
    J Cardiovasc Pharmacol; 1982; 4(2):205-12. PubMed ID: 6175802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological characterization of class III activity of a verapamil derivative in guinea-pig cardiac tissues.
    Kammer T; Berger F; Borchard U; Hafner D
    Arzneimittelforschung; 1993 Mar; 43(3):302-8. PubMed ID: 8489557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs.
    Nawada T; Tanaka Y; Hirai S; Hisatome I; Hasegawa J; Kotake H; Mashiba H
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):347-55. PubMed ID: 7952796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular electrophysiological effect of terikalant in the dog heart.
    Biliczki P; Acsai K; Virág L; Tálosi L; Jost N; Biliczki A; Papp JG; Varró A
    Eur J Pharmacol; 2005 Mar; 510(3):161-6. PubMed ID: 15763239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic and electrophysiological actions of flecainide, bepridil and amiodarone on isolated heart preparations during controlled hypoxia.
    Dietrich H; Borchard U; Hafner D; Hirth C
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):267-82. PubMed ID: 3875326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects.
    Hafner D; Berger F; Borchard U; Kullmann A; Scherlitz A
    Arzneimittelforschung; 1988 Feb; 38(2):231-6. PubMed ID: 3370070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative dromotropic effects of class I antiarrhythmic drugs in anisotropic ventricular muscle.
    Iida M; Kodama I; Toyama J
    Cardiovasc Res; 1996 Apr; 31(4):640-50. PubMed ID: 8689657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of flecainide on atrial and ventricular stimulation thresholds to repetitive extrasystoles and fibrillation and on "2nd Phase" ventricular arrhythmias in dogs.
    Heuer H; Gülker H; Thale J; Bender F
    Arzneimittelforschung; 1983; 33(12):1651-4. PubMed ID: 6199033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use- and concentration-dependent effects of flecainide in guinea pig right ventricular muscle.
    Rouet R; Ducouret P
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):177-83. PubMed ID: 7526048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of the slow-response action potential of mammalian ventricular myocardium by etafenone (author's transl)].
    Kohlhardt M
    Arzneimittelforschung; 1979; 29(2):218-21. PubMed ID: 582134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of BW A256C, a novel class 1 antiarrhythmic agent, on maximum rate of depolarisation of cardiac action potentials in vitro: frequency, use, and voltage dependence.
    Donoghue S; Payne PN; Allan G
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):12-8. PubMed ID: 2434786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model study of time- and voltage-dependent effects of class I antiarrhythmic drugs in guinea-pig papillary muscles as related to external potassium concentration.
    Hamamoto T; Kojima M; Matsuzaki M; Kusukawa R; Ban T
    Arzneimittelforschung; 1994 Aug; 44(8):929-37. PubMed ID: 7945535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.
    Slawsky MT; Castle NA
    J Pharmacol Exp Ther; 1994 Apr; 269(1):66-74. PubMed ID: 8169853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action potential, membrane currents and force of contraction in mammalian heart muscle fibers treated with quinidine.
    Nawrath H
    J Pharmacol Exp Ther; 1981 Jan; 216(1):176-82. PubMed ID: 7452504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophysiological effects of changrolin on single ventricular myocytes isolated from adult guinea pig].
    Liu QY; Chen WZ; Wei PJ; Gu PK; Jin ZJ
    Zhongguo Yao Li Xue Bao; 1989 Nov; 10(6):526-9. PubMed ID: 2641851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terikalant modifies the contractility and effective refractory period of heart muscle: comparative study in rats and guinea pigs.
    Kocić I
    Pol J Pharmacol; 1998; 50(4-5):327-31. PubMed ID: 10091717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue.
    Wang Z; Fermini B; Nattel S
    J Pharmacol Exp Ther; 1993 Nov; 267(2):575-81. PubMed ID: 8246130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of a diethylamino analog of ethmozine on the force of contraction and action potential of the guinea pig myocardium].
    Nesterenko VV; Rozenshtraukh LV
    Biull Eksp Biol Med; 1983 Aug; 96(8):56-9. PubMed ID: 6882907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.